Ally Bridge Group: Invited Member
Precondition: Apex Participant · Complimentary · Includes 2 Ads
Invited Member — Apex Ecosystem

Ally Bridge Group

Apex Member Partner — Hong Kong & New York

Apex Business Group Worldwide presents Ally Bridge Group — Ally Bridge Group is a global healthcare-focused investment firm with offices in Hong Kong and New York. The firm backs pioneering life sciences companies with a multi-stage strategy spanning venture... Connecting visionary founders with the global Apex ecosystem across 80+ countries.

What Apex Is

Apex is a living ecosystem — one of its kind. A decentralized, member-owned global business platform across 80+ countries where preferred venture partners such as Ally Bridge Group can explore early-stage innovation quietly and selectively, while founders showcase on their MySite and gain clarity on what long-term investors truly seek. No middleman. By members, for members.

Ally Bridge Group

Ally Bridge Group is a global healthcare-focused investment firm with offices in Hong Kong and New York. The firm backs pioneering life sciences companies with a multi-stage strategy spanning venture capital, growth equity, public market funds, and buyouts.

Ally Bridge uses its global reach to connect transformative healthcare technologies with international markets, addressing major unmet medical needs. The firm has achieved more than 50 exits and invested across oncology, rare diseases, diagnostics, and medical devices.

Founded in 2013, Ally Bridge Group combines deep scientific expertise with financial acumen, providing portfolio companies with regulatory guidance, clinical development support, and access to both Asian and Western healthcare markets.

Mission: We back pioneering life sciences companies — 50+ exits, multi-stage healthcare investing from Hong Kong and New York since 2013.
www.allybridgegroup.com
Hong Kong & New York
Key Figures
$5M–$50M
Ticket Size
Venture to Public
Investment Focus
Asia & US
Geographic Focus
Life Sciences
Core Theme
Healthcare
Core Theme
Multi-Stage
Investment Vehicle
50+ Exits
Track Record
Invited
Apex Role

"Pioneering life sciences investing — 50+ exits, connecting transformative healthcare technologies between Asia and Western markets."

— Ally Bridge Group

Apply to the Apex Startup Discovery Program

Aligned with Ally Bridge Group's investment focus. Precondition: You must be an Apex Participant to submit.

⚠️
Precondition: You must be an Apex Participant to submit. Registration at myapex.me is complimentary and includes 2 Golden Ads.

1. Founder & Company
Basic information.

"50+ exits. Life sciences. Hong Kong + New York. Multi-stage healthcare investing." — Ally Bridge
What draws you to Ally Bridge's 50+ exit healthcare track record, Hong Kong-New York platform, and multi-stage life sciences approach?

2. Problem & Technology
"$5M–$50M. Venture to public. Oncology. BioTech. Medical devices." — Ally Bridge
Ally Bridge invests in healthcare. Describe your clinical innovation, regulatory strategy, and how Asia-US market access can accelerate your growth.

3. Market & Traction

4. Funding
Ally Bridge Group invests $5M–$50M from venture to public markets in life sciences and healthcare companies across Asia and the US.
"Transformative healthcare. Global reach. Clinical development. Regulatory guidance." — Ally Bridge
What draws you to Ally Bridge's 50+ exit healthcare track record, Hong Kong-New York platform, and multi-stage life sciences approach?

5. Additional
Disclaimer · Full Legal Notice →

Apex Business Group Worldwide SL does not act as an investment broker. Ally Bridge Group is an invited member. Submission does not guarantee review or investment. All participation is voluntary and non-binding.

info@abc-worldwide.com · Book an Apex Expert

Apex Ecosystem with Golden Ads

"Who I Am · What I Want" — Complimentary at myapex.me — includes 2 Golden Ads.

Become an Apex Participant →

Join the Apex Ecosystem

Whether founder or investor — Apex is built for you.

Become a ParticipantExhibitSchedule